SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:1221ae90-3a92-4bd9-9cc9-1ed9645ca0dd"
 

Search: onr:"swepub:oai:lup.lub.lu.se:1221ae90-3a92-4bd9-9cc9-1ed9645ca0dd" > Noninvasive Assessm...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation

Corino, Valentina D. A. (author)
Sandberg, Frida (author)
Lund University,Lunds universitet,Avdelningen för Biomedicinsk teknik,Institutionen för biomedicinsk teknik,Institutioner vid LTH,Lunds Tekniska Högskola,Department of Biomedical Engineering,Departments at LTH,Faculty of Engineering, LTH
Mainardi, Luca T. (author)
show more...
Platonov, Pyotr (author)
Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
Sörnmo, Leif (author)
Lund University,Lunds universitet,Avdelningen för Biomedicinsk teknik,Institutionen för biomedicinsk teknik,Institutioner vid LTH,Lunds Tekniska Högskola,Department of Biomedical Engineering,Departments at LTH,Faculty of Engineering, LTH
show less...
 (creator_code:org_t)
2014-12-26
2015
English.
In: Annals of Noninvasive Electrocardiology. - : Wiley. - 1082-720X. ; 20:6, s. 534-541
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: During atrial fibrillation (AF), conventional electrophysiological techniques for assessment of refractory period or conduction velocity of the atrioventricular (AV) node cannot be used. We aimed at evaluating changes in AV nodal properties during administration of tecadenoson and esmolol using a novel ECG-based method. Methods: Fourteen patients (age 58 +/- 8 years, 10 men) with AF were randomly assigned to either 75 or 300 mu g intravenous tecadenoson. After tecadenoson wash-out, patients received esmolol continuously (100 mu g/kg per min for 10 mins, then 50 mu g/kg per min for 50 mins). Atrial fibrillatory rate (AFR) and heart rate (HR) were assessed in 15-min segments. Using the novel method, we assessed the absolute refractory periods of the slow and fast pathways (aRPs and aRPf) of the AV node to produce an estimate of the functional refractory period. Results: During esmolol infusion, AFR and HR were significantly decreased and the absolute refractory period was significantly prolonged in both pathways (aRPs: 387 +/- 73 vs 409 +/- 62 ms, P < 0.05; aRPf: 490 +/- 80 vs 529 +/- 58 ms, P < 0.05). During both tecadenoson doses, HR decreased significantly and AFR was unchanged. Both aRPs and aRPf were prolonged for a 75 mu g dose (aRPs: 322 +/- 97 vs 476 +/- 75 ms, P < 0.05; aRPf: 456 +/- 102 vs 512 +/- 55 ms, P < 0.05) whereas a trend toward prolongation was observed for a 300 mu g dose. Conclusions: The estimated parameters reflect expected changes in AV nodal properties, i.e., slower conduction through the AV node for tecadenoson and prolongation of the AV node refractory period for esmolol. Thus, the proposed approach may be used to assess drug effects on the AV node in AF patients.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

atrioventricular node
atrial fibrillation
functional refractory
period
tecadenoson
esmolol

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Corino, Valentin ...
Sandberg, Frida
Mainardi, Luca T ...
Platonov, Pyotr
Sörnmo, Leif
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Cardiac and Card ...
Articles in the publication
Annals of Noninv ...
By the university
Lund University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view